Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gaëtan des Guetz

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Microsatellite instability-high status as a pan-cancer biomarker for immunotherapy efficacyThierry Landre, Gaëtan Des Guetz
The Cochrane Database of Systematic Reviews|January 22, 2010
Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancerGaëtan Des Guetz, Bernard Uzzan, Jean-Francois Morere, et al.
Targeted Oncology|April 4, 2009
Microsatellite instability: a predictive marker in metastatic colorectal cancer?Gaëtan Des Guetz, Bernard Uzzan, Patrick Nicolas, et al.
Cancers|December 10, 2021
Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-AnalysisGaëtan Des Guetz, Thierry Landre, Marc A Bollet, et al.
Soins. Gerontologie|February 16, 2013
[Assessment of nursing needs and risk management in geriatric oncology]Cherifa Taleb, Thierry Landre, Eric Bertrand, et al.
Therapeutic Advances in Medical Oncology|December 21, 2020
First-line immune-checkpoint inhibitor plus chemotherapy <i>versus</i> chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysisThierry Landre, Kader Chouahnia, Gaëtan Des Guetz, et al.
Anticancer Research|May 16, 2009
Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysisGaëtan Des Guetz, Bernard Uzzan, Patrick Nicolas, et al.
JTO Clinical and Research Reports|June 15, 2026
Brief Report: Real-World Comparative Effectiveness of First-Line Immune Checkpoint Inhibitor Monotherapy Versus Chemo-Immunotherapy in Metastatic NSCLC With PD-L1 More Than or Equal to 50%: A Meta-AnalysisThierry Landre, Jean-Baptiste Assié, Kader Chouahnia, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2009
Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysisGaëtan Des Guetz, Olivier Schischmanoff, Patrick Nicolas, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|May 19, 2025
Clémence Schantz, Marie Bottin, Léa Prost-Lançon, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Cancer Immunology, Immunotherapy : CII|February 25, 2025
Microsatellite instability-high status as a pan-cancer biomarker for immunotherapy efficacyThierry Landre, Gaëtan Des Guetz
The Cochrane Database of Systematic Reviews|January 22, 2010
Duration of adjuvant chemotherapy for patients with non-metastatic colorectal cancerGaëtan Des Guetz, Bernard Uzzan, Jean-Francois Morere, et al.
Targeted Oncology|April 4, 2009
Microsatellite instability: a predictive marker in metastatic colorectal cancer?Gaëtan Des Guetz, Bernard Uzzan, Patrick Nicolas, et al.
Cancers|December 10, 2021
Is There a Benefit of Oxaliplatin in Combination with Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer? An Updated Meta-AnalysisGaëtan Des Guetz, Thierry Landre, Marc A Bollet, et al.
Soins. Gerontologie|February 16, 2013
[Assessment of nursing needs and risk management in geriatric oncology]Cherifa Taleb, Thierry Landre, Eric Bertrand, et al.
Therapeutic Advances in Medical Oncology|December 21, 2020
First-line immune-checkpoint inhibitor plus chemotherapy <i>versus</i> chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysisThierry Landre, Kader Chouahnia, Gaëtan Des Guetz, et al.
Anticancer Research|May 16, 2009
Microsatellite instability does not predict the efficacy of chemotherapy in metastatic colorectal cancer. A systematic review and meta-analysisGaëtan Des Guetz, Bernard Uzzan, Patrick Nicolas, et al.
JTO Clinical and Research Reports|June 15, 2026
Brief Report: Real-World Comparative Effectiveness of First-Line Immune Checkpoint Inhibitor Monotherapy Versus Chemo-Immunotherapy in Metastatic NSCLC With PD-L1 More Than or Equal to 50%: A Meta-AnalysisThierry Landre, Jean-Baptiste Assié, Kader Chouahnia, et al.
European Journal of Cancer (Oxford, England : 1990)|May 12, 2009
Does microsatellite instability predict the efficacy of adjuvant chemotherapy in colorectal cancer? A systematic review with meta-analysisGaëtan Des Guetz, Olivier Schischmanoff, Patrick Nicolas, et al.
Sante Publique (Vandoeuvre-Les-Nancy, France)|May 19, 2025
Clémence Schantz, Marie Bottin, Léa Prost-Lançon, et al.
Pageof 2